A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial
- Ming Huang Chen
- , Johnson Lin
- , Chin Fu Hsiao
- , Yan Shen Shan
- , Yeu Chin Chen
- , Li Tzong Chen
- , Tsang Wu Liu
- , Chung Pin Li
- , Yee Chao
Research output: Contribution to journal › Article › peer-review
3
Link opens in a new tab
Citations
(Scopus)